Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite-Reference-Cited by-同舟云学术

Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite

Published:2001-03 Issue:2-3 Volume:415 Page:181-189
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Carlson Jeffrey N,Haskew Rene,Wacker Jennifer,Maisonneuve Isabelle M,Glick Stanley D,Jerussi Thomas P

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum;Blanchard;J. Neurochem.,1983

2. Regional rat brain benzodiazepine receptor number and gamma-aminobutyric acid concentration following a convulsion;Bowdler;Br. J. Pharmacol.,1982

3. The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines;Concas;Naunyn-Schmiedeberg's Arch. Pharmacol.,1994

4. Evaluation of zopiclone physical dependence liability in normal volunteers;Dorian;Pharmacology,1983

5. Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies;Facklam;J. Pharmacol. Exp. Ther.,1992

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders due to Substance Use: Sedatives, Hypnotics, and Anxiolytics;Tasman’s Psychiatry;2024

2. Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond;Frontiers in Psychiatry;2023-06-23

3. Disorders Due to Substance Use: Sedatives, Hypnotics, and Anxiolytics;Tasman’s Psychiatry;2023

4. Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review;Frontiers in Neuroscience;2022-07-29

5. NEWLY SYNTHESIZED AMANTАDINE DERIVATIVE: SAFETY AND NEUROPHARMACOLOGICAL ACTIVITY;FARMACIA;2021-12-24